Don’t take our word for it!
Read some of our Customer Stories
For development of the breakthrough MultiPath platform and culture-free, anti-microbial susceptibility tests
Commits to deliver platform to enable targeted treatment at the onset of infection
Two-day event highlights investment trends and opportunities in Life Sciences
New Senior VP of R&D and Regulatory Affairs will help guide product development and regulatory clearance.
New videos include 1-1 clinician interviews and detailed product tour
Additional funds to support the company's diagnostic platform initiatives
FDA clearance is part of Company's three-part strategy to change the business paradigm for the molecular diagnostic industry
InDevR receives 510(k) market clearance for the first influenza diagnostic assay capable of distinguishing between seasonal and non-seasonal influenza A subtypes.
Industry Experts to Support Development and Commercialization
New facility offers additional space, state of the art laboratory, added manufacturing capacity
Startup introduces streamlined, robust workflow for NGS sample preparation and analysis
Flow cytometry provides a highly adaptable and quantitative method for investigating both the cellular distribution and intracellular changes that occur in tumors and peripheral lymphoid organs in response to therapy.
Session to examine how medical device and diagnostic equipment companies can use IoT to provide innovative, compliant and secure healthcare solutions
Precision Analytical, Inc., a functional medicine specialty lab, launches six (6) organic acid tests (OATs)
Live discussion with FDA and Siemens to provide an overview of the use of individualized computer simulation to predict clinical outcomes in medical device trials
Flexible, Fast, Efficient: The Expanding Role of Single-Site PMA Approval in Companion Diagnostics Development
Immunoprecipitation in combination with mass spectrometry is a powerful tool for studying disease-associated proteins
InDevR gearing up to launch FluChip-8G with AI interpretation of microarray 'big data' to enhance influenza surveillance